Bill Cassidy actually said...
Our top priority was ensuring that the relevant data pertaining to the safety and effectiveness of both vaccines were available for public consideration before we decided whether to authorize these COVID-19 vaccines for pediatric populations.
Context
Cassidy emphasizes the importance of data transparency before vaccine authorization.
06/15/2022